150 related articles for article (PubMed ID: 36880170)
1. Exploitation of a novel adjuvant for polymyxin B against multidrug-resistant Acinetobacter baumannii.
Kim SY; Seo HW; Park MS; Park CM; Seo J; Rho J; Myung S; Ko KS; Kim JS; Ryu CM
J Antimicrob Chemother; 2023 Apr; 78(4):923-932. PubMed ID: 36880170
[TBL] [Abstract][Full Text] [Related]
2. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
3. Model-informed dose optimisation of polymyxin-rifampicin combination therapy against multidrug-resistant Acinetobacter baumannii.
Zhao J; Zhu Y; Han ML; Lu J; Yu HH; Wickremasinghe H; Zhou QT; Bergen P; Rao G; Velkov T; Lin YW; Li J
Int J Antimicrob Agents; 2023 Sep; 62(3):106902. PubMed ID: 37380093
[TBL] [Abstract][Full Text] [Related]
4. Polymyxin dose tunes the evolutionary dynamics of resistance in multidrug-resistant Acinetobacter baumannii.
Zhao J; Zhu Y; Lin YW; Yu H; Wickremasinghe H; Han J; Velkov T; McDonald MJ; Li J
Clin Microbiol Infect; 2022 Jul; 28(7):1026.e1-1026.e5. PubMed ID: 35283314
[TBL] [Abstract][Full Text] [Related]
5. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
Thomas VM; Brown RM; Ashcraft DS; Pankey GA
Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
[TBL] [Abstract][Full Text] [Related]
7. The Low-Alkalinity Polymyxin Derivative, AL-6, Shows High Activity Against Multidrug-Resistant
Chen DJ; Cui AL; Chen JR; Yang P; Jin J; Shao L; Li ZR
Microb Drug Resist; 2021 Jul; 27(7):933-941. PubMed ID: 33544031
[TBL] [Abstract][Full Text] [Related]
8. Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance.
Cheah SE; Li J; Tsuji BT; Forrest A; Bulitta JB; Nation RL
Antimicrob Agents Chemother; 2016 Jul; 60(7):3921-33. PubMed ID: 27067324
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
Akin FE; Bayram A; Balci I
Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
[TBL] [Abstract][Full Text] [Related]
10. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
[TBL] [Abstract][Full Text] [Related]
11.
Duncan LR; Wang W; Sader HS
Antimicrob Agents Chemother; 2022 May; 66(5):e0013922. PubMed ID: 35475635
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Inhibitory Effect of Polymyxin B in Combination with Ceftazidime against Robust Biofilm Formed by Acinetobacter baumannii with Genetic Deficiency in AbaI/AbaR Quorum Sensing.
Li Y; Wang B; Lu F; Ahn J; Zhang W; Cai L; Xu J; Yin Y; Cao Q; Ren Z; He X
Microbiol Spectr; 2022 Feb; 10(1):e0176821. PubMed ID: 35196792
[TBL] [Abstract][Full Text] [Related]
13. Origanum vulgare essential oil: antibacterial activities and synergistic effect with polymyxin B against multidrug-resistant Acinetobacter baumannii.
Amaral SC; Pruski BB; de Freitas SB; Allend SO; Ferreira MRA; Moreira C; Pereira DIB; Junior ASV; Hartwig DD
Mol Biol Rep; 2020 Dec; 47(12):9615-9625. PubMed ID: 33190200
[TBL] [Abstract][Full Text] [Related]
14. A novel decoy strategy for polymyxin resistance in
Park J; Kim M; Shin B; Kang M; Yang J; Lee TK; Park W
Elife; 2021 Jun; 10():. PubMed ID: 34180396
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii.
Chung JH; Bhat A; Kim CJ; Yong D; Ryu CM
Sci Rep; 2016 Jun; 6():28168. PubMed ID: 27306928
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of Eucalyptus camaldulensis essential oils and their interactions with conventional antimicrobial agents against multi-drug resistant Acinetobacter baumannii.
Knezevic P; Aleksic V; Simin N; Svircev E; Petrovic A; Mimica-Dukic N
J Ethnopharmacol; 2016 Feb; 178():125-36. PubMed ID: 26671210
[TBL] [Abstract][Full Text] [Related]
17. Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates.
Girardello R; Visconde M; Cayô R; Figueiredo RC; Mori MA; Lincopan N; Gales AC
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):37-44. PubMed ID: 27776788
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
Doymaz MZ; Karaaslan E
Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
[No Abstract] [Full Text] [Related]
19. Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates.
Barin J; Martins AF; Heineck BL; Barth AL; Zavascki AP
Ann Clin Microbiol Antimicrob; 2013 Jul; 12():15. PubMed ID: 23819554
[TBL] [Abstract][Full Text] [Related]
20. Polymyxin B Heteroresistance and Adaptive Resistance in Multidrug- and Extremely Drug-Resistant Acinetobacter baumannii.
Genteluci GL; de Souza PA; Gomes DBC; Sousa VS; de Souza MJ; Abib JRL; de Castro EAR; Rangel K; Villas Bôas MHS
Curr Microbiol; 2020 Sep; 77(9):2300-2306. PubMed ID: 32494882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]